Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter

被引：0
作者：
Sonal Gandhi
Sunil Verma
机构：
[1] University of Toronto,
[2] Toronto Sunnybrook Regional Cancer Centre,undefined
来源：
Breast Cancer Research and Treatment | 2007年 / 106卷
关键词：
Adjuvant therapy; Aromatase inhibitors; Breast cancer; Cardiovascular events; Lipids; Tamoxifen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent advances in breast cancer treatment include the advent of aromatase inhibitors (AIs) in the adjuvant setting with better efficacy and toxicity profiles than tamoxifen. However, AIs generally do not improve lipid profile as tamoxifen does, and there has been suggestion of increased cardiovascular risk with AI use. This has become an area of concern, particularly in light of the view that tamoxifen may protect against cardiovascular disease. This review of the current literature and updated trial data examines the effect both AIs and tamoxifen have on lipids and cardiovascular risk. It also highlights the importance of interpreting such data within the larger context of cardiovascular health in postmenopausal women.
引用
收藏
页码：1 / 9
页数：8
相关论文
共 111 条
  • [21] Evans MC(2001)Effects of hormone replacement therapy on serum lipid in elderly women; a randomized placebo-controlled trial Ann Intern Med 134 754-760
  • [22] Nabholtz JM(1994)Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women Arterioscler Thromb 14 275-281
  • [23] Gligorov J(1989)High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 8-15
  • [24] Venturini M(1984)The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering JAMA 251 365-374
  • [25] Del Mastro L(1998)Hypertriglyceridemia as a cardiovascular risk factor Am J Cardiol 81 7B-12B
  • [26] Pritchard KI(2006)Hypertension, menopause, and coronary artery disease risk in the Women’s Ischemia Syndrome Evaluation (WISE) study J Am Coll Cardiol 47 S50-S58
  • [27] Abramson BL(2001)Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation JAMA 286 180-187
  • [28] Howell A(2004)Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study Lancet 364 937-952
  • [29] Cuzick J(1998)Prediction of coronary heart disease using risk factor categories Circulation 97 1837-1847
  • [30] Esteva FJ(1992)Long term effects of tamoxifen. Biological effects of tamoxifen Working Party Eur J Cancer 29A 15-21
12345678910